Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY: CVS )

63.10 +0.86 (+1.39%)
Streaming Delayed Price Updated: 12:58 PM EDT, Oct 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,304,742
Open 61.95
Bid (Size) 63.09 (2)
Ask (Size) 63.11 (2)
Prev. Close 62.24
Today's Range 61.46 - 63.22
52wk Range 52.77 - 83.25
Shares Outstanding 1,319,574,744
Dividend Yield 3.83%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Unpacking the Latest Options Trading Trends in CVS Health
Via Benzinga
Humana Stock Dives On Medicare Ratings; UnitedHealth Tries To Bounce
Humana Medicare Advantage plans are getting a big star-ratings cut. 
Via Investor's Business Daily

Performance

YTD
-21.95%
-21.95%
1 Month
+9.98%
+9.98%
3 Month
+11.30%
+11.30%
6 Month
-15.41%
-15.41%
1 Year
-8.87%
-8.87%

More News

Read More
What Analysts Are Saying About CVS Health Stock
Via Benzinga
CVS Health Mulls Split Of Retail And Insurance Divisions To Address Financial Challenges: Report
Via Benzinga
Instacart Is Revolutionizing Groceries: Why It's Time to Invest
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Stock Of The Day: Is It Time To Sell CVS?
Via Benzinga
CVS Health's Options: A Look at What the Big Money is Thinking
Via Benzinga
Spotlight on CVS Health: Analyzing the Surge in Options Activity
Via Benzinga
Apple, Nio, CVS Health, Stellantis, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Via Benzinga
Topics Stocks
Exposures US Equities
CVS Health in Focus as Activist Investor Prepares for High-Level Talks
Via Benzinga
CVS ALERT: Bragar Eagel & Squire, P.C. is Investigating CVS Health Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Here’s Why Surgery Partners Could Be the Next Hot Takeover
Via MarketBeat
Is CVS Health Stock a Buy?
Via The Motley Fool
Are CVS Health, Cigna, and UnitedHealth Group Stocks Bad News Buys With the FTC's PBM Crackdown?
Via The Motley Fool
UnitedHealth Vs. CVS Vs. Cigna: Which Health Stock Will Beat The FTC's Regulatory Heat?
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Eli Lilly Fights $183M Medicaid Fraud Judgment, Cites Reasonable Interpretation Of Medicaid Rules
Via Benzinga
Topics Fraud
Exposures Legal
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
Via Benzinga
CVS Subsidiary Oak Street Health Agrees to $60M Settlement in Medicare Kickback Violations
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
4 Dividend Stocks to Double Up On Right Now
Via The Motley Fool
CVS ALERT: Bragar Eagel & Squire, P.C. is Investigating CVS Health Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Walgreens Agrees To $106.8M Settlement Over Alleged False Billing Claims
Via Benzinga
Topics Lawsuit Whistleblower
Exposures Financial Legal
3 Overlooked Stocks With Strong Value and Dividend Potential
Via MarketBeat
PayPal Is A Buy, Jim Cramer Says: As For Rivian? 'Let It Percolate'
Via Benzinga
UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.